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Abstract
Background
Breast tissue composition is recognized as a strong and independent risk factor for breast
cancer. It is a heritable feature, but is also significantly affected by several other elements
(e.g., age, menopause). Nowadays it is quantified by mammographic density, thus requiring
the use of ionizing radiation. Optical techniques are absolutely non-invasive and have al-
ready proved effective in the investigation of biological tissues, as they are sensitive to tis-
sue composition and structure.
Methods
Time domain diffuse optical spectroscopy was performed at 7 wavelengths (635-1060 nm)
on 200 subjects to derive their breast tissue composition (in terms of water, lipid and colla-
gen content), blood parameters (total hemoglobin content and oxygen saturation level), and
information on the microscopic structure (scattering amplitude and power). The depen-
dence of all optically-derived parameters on age, menopausal status, body mass index,
and use of oral contraceptives, and the correlation with mammographic density were
investigated.
Results
Younger age, premenopausal status, lower body mass index values, and use of oral contra-
ceptives all correspond to significantly higher water, collagen and total hemoglobin content,
and lower lipid content (always p < 0.05 and often p < 10-4), while oxygen saturation level
and scattering parameters show significant dependence only on some conditions. Even
when age-adjusted groups of subjects are compared, several optically derived parameters
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(and in particular always collagen and total hemoglobin content) remain significantly
different.
Conclusions
Time domain diffuse optical spectroscopy can probe non-invasively breast tissue composi-
tion and physiologic blood parameters, and provide information on tissue structure. The
measurement is suitable for in vivo studies and monitoring of changes in breast tissue (e.g.,
with age, lifestyle, chemotherapy, etc.) and to gain insight into related processes, like the or-
igin of cancer risk associated with breast density.
Introduction
Breast tissue composition is essentially determined by the relative proportion of epithelial tis-
sue, stroma and fat. It is a heritable feature, but it is also significantly affected by factors like
age, pregnancy, and menopause [1,2,3,4]. Breast tissue composition is recognized as a strong
and independent risk factor for breast cancer [5,6,7]. At present, it is generally quantified by
mammographic density. Thus, its assessment involves the use of ionizing radiation.
Optical techniques, including both spectroscopy and imaging, are absolutely non-invasive
and can be effectively applied in vivo to derive information on tissue composition and structure
[8,9,10]. Over the years, most of the work performed in the optical field has been devoted to
the detection of breast cancer and the monitoring of cerebral hemodynamics, and has focused
on the assessment of oxy- and deoxyhemoglobin content or on their relative variations. How-
ever, some research groups have successfully developed and applied optical instruments that
allow also the quantification of water and lipids in breast tissue [11][12] and of scattering pa-
rameters that are related to the overall structure of tissue at microscopic level [13][14].
Our group has longed worked on the development of advanced optical systems and their ap-
plication for the non-invasive characterization of biological tissues [15,16,17,18]. The time do-
main approach we adopt consists in injecting short (picosecond) light pulses into the tissue
and measuring the pulses that are re-emitted after propagation through the tissue. The shape
of the re-emitted pulse depends on the optical properties of the medium. Thus, its analysis al-
lows one to perform a complete optical characterization of the medium with the independent
assessment of both the absorption and scattering coefficients. When time domain measure-
ments are carried out (and the absorption properties are consequently measured) at several
wavelengths, then tissue composition can be estimated from the Beer law. For a more complete
and accurate tissue characterization, we have progressively extended the spectral range of oper-
ation of our instruments, which allowed us to quantify in vivo not only blood parameters,
water and lipids, but also collagen [19]. Moreover, information on tissue structure at a micro-
scopic level is obtained from the scattering parameters (amplitude and power). In fact, a simple
empirical approximation to Mie theory relates them to the concentration and equivalent size of
scattering centers (cells, nuclei, and organelles) in tissue [20][21].
Previously, we have combined these pieces of information specifically aiming at the non-in-
vasive optical assessment of breast density and identification of subjects that are at high risk for
developing breast cancer because of their high breast density [22][23].
More in general, in the present work we show how time domain diffuse optical spectroscopy
can effectively be used to study the dependence of breast tissue composition (water, lipid and
collagen concentrations, total hemoglobin content and oxygen saturation level) and structure
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(scattering amplitude and power) on various demographic parameters (age, menopausal status,
body mass index, use of oral contraceptives).
The availability of a fully non-invasive means to provide quantitative information on tissue
composition and monitor its changes could be exploited to achieve a better understanding of
breast physiology and of the biological basis of breast cancer, and could contribute to foster the
development of personalized medicine procedures.
Methods
Instrument set-up
Our portable clinical instrument for time-resolved optical mammography operates in trans-
mittance geometry, i.e., in the same geometry as x-ray mammography.
Seven pulsed diode lasers (LDH-P-XXX, PicoQuant, Germany, where XXX represents the
nominal wavelength in nanometers) are used as light sources emitting at 635, 685, 785, 905,
930, 975 and 1060 nm, with average output powers of ~1–5 mW, temporal widths of ~150–
400 ps (full width at half maximum, FWHM), and repetition rates of 20 MHz. A single driver
(PDL-808 “Sepia”, PicoQuant, Germany) controls all the laser heads, and their output pulses
are properly delayed by means of graded index optical fibers, and combined into a single cou-
pler. Circular variable neutral density filters in each of the 7 illumination paths allow optimiza-
tion of the illumination power at each wavelength separately. The breast is softly compressed
between parallel antireflection-coated tempered glass plates. A fiber bundle collects the output
light on the opposite side of the compression unit. The distal end of the bundle is bifurcated,
and its two legs guide photons respectively to a photomultiplier tube (PMT) for the detection
of wavelengths<850 nm (R5900U-01-L16, Hamamatsu, Japan) and to a PMT for longer wave-
lengths (H7422P-60, Hamamatsu, Japan). Circular variable neutral density filters, placed in
front of each PMT, are used to control the illumination power during in vivomeasurements
and for the acquisition of the instrument response function. In particular, for in vivomeasure-
ments the attenuators are automatically rotated by computer-controlled stepper motors to
reach a pre-set number of counts (2 x 105 counts/s) at each wavelength in a reference position
(i.e. close to the chest wall). Two personal computer (PC) boards for time-correlated single
photon counting (SPC134, Becker&Hickl, Germany) allow the acquisition of time-resolved
transmittance curves at wavelengths shorter and longer than 850 nm, respectively. Depending
on the wavelength, the instrument response function ranges between 460 and 930 ps (FWHM).
The illumination fiber and collecting bundle are scanned in tandem and a feedback on the
total number of counts per point, ruled by an adjustable threshold, restricts the scan to the
breast area. To minimize dead times, continuous acquisition is performed and data are stored
every millimeter of path, i.e. every 25 ms. The scan time depends on the area of the compressed
breast that needs to be imaged, but is typically around 5 min. Notwithstanding measurement
times significantly longer than required by x-ray mammography, the great majority of the sub-
jects who participated in the study did not report any significant discomfort, and overall they
judged the optical measurement more acceptable than x-ray mammography. When some com-
plaint was made, it was on the still position that could cause discomfort to the back more than
on the compression itself.
The compression unit can be rotated by an angle up to 90° in both clock-wise and counter-
clock-wise direction, so that images of both breasts can be recorded in the cranio-caudal (CC)
as well as medio-lateral or oblique (OB, at 45°) views.
The entire set-up is a stand-alone instrument (50 cmW x 80 cm D x 140 cm H), mounted
on wheels and approved by the Italian Ministry of Health for use in a clinical environment.
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Details on the instrument set-up and performances, and on the procedures for data acquisition
and analysis are reported in [24].
Ethics statement
Written informed consent was obtained from all subjects and all protocols were approved by
the Institutional Review Board of the European Institute of Oncology (study n°. S305/306).
Subjects and measurement procedure
Data were collected between 2009 and 2013 from 200 subjects as part of a study on the optical
characterization of malignant and benign breast lesions and the optical assessment of breast tis-
sue composition and structure for the non-invasive estimate of breast density. Ninety-five sub-
jects had a malignant lesion and 27 had a benign lesion. Demographic information on the
subjects involved in the study is reported in Table 1 and S1 File.
From each subject, four sets of 7-wavelength transmittance images were acquired (i.e. CC
and OB views of both breasts). For the entire duration of the acquisition, the subject was
sitting comfortably.
Recent (less than 1 year old) x-ray mammograms of the same views were generally available
or were acquired in the same measurement session as optical images.
Data analysis
Optical data. Concerning optical data, light propagation in breast tissue was modeled
using the diffusion approximation to the radiative transport theory with extrapolated boundary
condition, for a homogeneous infinite slab [25][26]. This allowed us to estimate the optical
properties (absorption and reduced scattering coefficient, μa and μ's, respectively) at 7 wave-
lengths. Information on tissue composition and structure were obtained directly from time-re-
solved transmittance curves measured at the 7 wavelengths. The Beer law was used to relate the
absorption properties μa(λ) at the wavelength λ to the concentrations ci of the main tissue con-
stituents:
maðlÞ ¼
P
iciεiðlÞ; ð1Þ
where εi(λ) is extinction coefﬁcient of the i-th constituent at the wavelength λ. The scattering
Table 1. Subject demographicsa (N = 200).
Age (y) 52.2± 11.7 (30.0–79)
Height (cm) 162 ± 6 (147–180)
Weight (kg) 62.4 ± 11.1 (43.0–107)
BMI (kg/m2) 23.6 ± 3.8 (16.5–35.5)
Premenopausal status N = 93b
Postmenopausal status N = 102
Use of OCs N = 88b
No use of OCs N = 110
aAverage and standard deviation (range) of continuous variables and number N of subjects in a speciﬁc
condition for categorical variables.
bInformation was not available for N = 5 subjects on menopausal status and for N = 2 subjects on the use
of OCs.
doi:10.1371/journal.pone.0128941.t001
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properties were modeled through a simple approximation to Mie theory:
m
0
sðlÞ ¼ a
l
lo
 b
; ð2Þ
where λo = 600 nm,a is the reduced scattering coefﬁcient μ’s(λo), and b is the scattering power,
which describes the slope of the scattering spectrum [20][21]. A spectrally constrained global
ﬁtting procedure was applied that provides robust results even when the data are collected at a
limited number of wavelengths [27]. Free parameters of the ﬁt were the concentrations of oxy-
and deoxy-hemoglobin (HbO2 andHb, respectively), water, lipids, and collagen, together with
the scattering amplitude a and power b. From Hb and HbO2, the total hemoglobin content
tHb = Hb + HbO2 and the oxygen saturation level SO2 =HbO2/tHb were then calculated.
For each image pixel (1 mm2), this procedure provided optical properties, tissue composi-
tion and information on microscopic structure averaged along the line of site between injection
and collection points. Then, for each subject all data from the four images (CC and OB views
of both breasts) were averaged to provide the average characterization of the breast tissue of
that subject (S1 File). Regions of marked inhomogeneity (as observed in the case of some
breast lesions and close to the boundaries of the compressed breast that may be affected by
measurement artefacts) were excluded from the average [24].
X-ray mammographic images. When available (N = 189), recent x-ray mammograms
were analyzed to assess the mammographic density. An expert radiologist (FA) assigned Breast
Imaging and Reporting Data System (BI-RADS) mammographic density categories as: i) al-
most entirely fat (category 1, N = 27); ii) scattered fibroglandular densities (category 2, N = 55);
iii) heterogeneously dense (category 3, N = 70); and iv) extremely dense (category 4, N = 37)
[28].
Statistical analysis. The statistical significance of the difference between two groups (e.g.,
water content in premenopausal vs. postmenopausal subjects) was assessed using the Mann-
Whitney test at alpha = 0.05. Significance was considered when p< 0.05.
When regression was adopted to model the relationship between continuous variables (e.g.,
water content vs. age), the adjusted R2 value was used to estimate the percentage of the varia-
tion of the dependent variable that can be accounted for by the regression model.
The linear correlation between blood parameters (either tHb or SO2) and lipid content in
pre- and post-menopausal women was appraised through the Pearson correlation coefficient r.
Statistical analysis was performed using IBM SPSS Statistics Release 21 and Minitab Version
16.
Results and Discussion
Breast density
The optical properties (both absorption and scattering) of breast tissue reflect its composition
and consequently show marked inter-subject variation. Mammographic density is generally
used as a measure of breast tissue composition [28]. Thus the easiest way to investigate inter-
subject differences is to compare the optical properties of breasts belonging to different BI-R-
ADS categories, spanning from almost entirely fat (category 1) to extremely dense (category 4).
Fig 1 shows the average absorption and scattering spectra corresponding to distinct BI-RADS
categories. The major differences in breast tissue composition corresponding to different mam-
mographic categories are already evident when looking at the absorption spectra. In particular,
the spectrum of dense breasts is dominated by the absorption of water, that in vivo is expected
to peak around 970 nm, while the sharper peak of lipids centered around 930 nm stands out in
the case of adipose breasts. The higher collagen content in tissue with a high fibroglandular
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fraction is less apparent, because in this spectral range the protein is characterized by weak ab-
sorption as compared to the other major constituents. However, it still contributes non-negligi-
bly to the higher absorption of dense breasts at the longest wavelength (1060 nm).
Differences are observed also in the scattering properties (Fig 1B). Stroma and epithelium
are abundant in dense breasts. As compared to adipose tissue, they are characterized by higher
scattering, decreasing with steeper slope as a function of wavelength. This indicates that in
dense tissue there is a higher number of “scattering centers”, namely interfaces that alter the di-
rection of propagation of photons at microscopic level, causing light diffusion (higher ampli-
tude a). Moreover, these centers have smaller average size (higher scattering power b).
Data fitting to the diffusion theory allows us to derive quantitative information on the dif-
ferent properties of tissue of different mammographic density, as shown in Table 2. Upon in-
creasing mammographic density from BI-RADS category 1 to 4, all optically derived
parameters except SO2 gradually change, in agreement with the expected change in tissue com-
position that determines the progressively higher attenuation of x-rays leading to higher BI-R-
ADS reading. In particular, water and collagen, major constituents of dense stroma, increase
while lipids decrease. Correspondingly, both scattering parameters (a and b) gradually grow.
Increased vascularization and metabolism could be expected in dense tissue, leading to higher
total hemoglobin content tHb and lower oxygen saturation SO2. Based on optical outcomes,
Fig 1. Average absorption and reduced scattering spectra of 189 subjects classified in different BI-RADS categories. A) Absorption spectra andB)
reduced scattering spectra averaged overN = 27 subjects in Bi-RADS category 1 (red diamonds),N = 55 subjects in category 2 (orange squares),N = 70
subjects in category 3 (green triangles), andN = 37 in category 4 (blue circles). The error bars show the standard deviation of the absorption (A) or reduced
scattering (B) values calculated on all subjects that belong to the same BI-RADS category.
doi:10.1371/journal.pone.0128941.g001
Table 2. Tissue composition and scattering parameters of subjects in different BI-RADS categories.
BI-RADS Watera (mg/cm3) Lipida (mg/cm3) Collagena (mg/cm3) tHba (μM) SO2
a (%) aa (cm-1) ba (-)
1 (N = 27) 75.01 (14.89) 775.10 (43.82) 44.94 (18.20) 8.76 (1.49) 89.83 (6.52) 11.40 (0.81) 0.43 (0.10)
[0.0037]b - - - - - -
2 (N = 55) 97.76 (53.99) 739.16 (75.53) 50.90 (21.06) 9.27 (3.16) 89.19 (8.10) 12.00 (2.30) 0.48 (0.15)
[<10–4]b [<10–4]b [<10–4]b [0.0028]b - [0.0003]b [0.0001]b
3 (N = 70) 193.26 (111.07) 647.85 (112.24) 67.23 (44.99) 10.85 (2.81) 87.22 (10.23) 14.04 (3.36) 0.62 (0.24)
[0.0001]b [<10–4]b [0.0112]b [0.0493]b - [0.0049]b [<10–4]b
4 (N = 37) 330.91 (167.43) 531.70 (119.00) 113.80 (34.07) 14.86 (4.22) 86.68 (10.90) 15.12 (2.24) 1.05 (0.292)
aAverage values and standard deviation (in round brackets).
bIn square brackets, p-value (Mann-Whitney test) for the difference between the mean values reported in the above and below cells (e.g., water content
for subjects in BI-RADS category 1 vs 2). Reported only when signiﬁcant (p < 0.05).
doi:10.1371/journal.pone.0128941.t002
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the former hypothesis is confirmed, while the latter is only supported by the decreasing average
values, while no statistical difference is observed when adjacent BIRADS categories are com-
pared (Table 2).
Age
Increasing age generally determines a progressive decrease in mammographic density, ex-
plained with a change in the composition of breast tissue, where translucent adipose tissue
progressively replaces the radio-opaque epithelial and stromal components [29]-[30][31].
Data reported in the literature show that the change is evident upon increasing age up to ap-
proximately 50 y, while no clear trend of variation seems to be present thereafter [32]. As
shown in Fig 2A and 2B, data on optically derived tissue composition upon increasing age are
spread, but they confirm some decrease in water and collagen content (fibroglandular fraction
of tissue) and corresponding increase in the lipid content (adipose fraction). Some correspon-
dence with the reported dependence of mammographic density on age [32] is confirmed by the
fact that the quadratic regression of an optically derived tissue constituent (water, lipids or col-
lagen) versus age performs better than the linear one, even though only slightly (e.g., R2 =
32.7% for the quadratic regression of water vs. age, and R2 = 28.7% for the linear regression).
Alternatively, the comparison of the linear regression performed on data for age 50 y
and> 50 y could be considered. As an example, in the case of water, the fitting lines are Y =
-9.623X + 672.2 (r = 0.31) for the former group and Y = -2.036X + 245.8 (r = 0.23) for the latter
one, confirming a much clearer decrease in younger women ( 50 y).
More in detail, as displayed in Table 3, on average the breasts of younger women (50 y)
are characterized by significantly higher water and collagen content than the breasts of older
ones (> 50 y) while the opposite trend is observed for the lipid content. The total hemoglobin
content tHb and both scattering parameters are also significantly higher in younger women, in
agreement with the higher weight of the fibroglandular fraction (water and collagen).
It is interesting to observe that the relative difference in the amount of collagen between
younger and older women, measured here in vivo non-invasively, agrees very well with what
reported in the literature for the quantification of collagen performed on 3-μm thick histologic
sections obtained from women in the same age categories [33].
When the whole population is considered, the total hemoglobin content tHb decreases
slightly with age, while the oxygenation level SO2 does not show any significant dependence on
age (Fig 2C and 2D). A slight decrease with age is also observed for both scattering amplitude
a and power b, as expected based on the increasing lipid content (Fig 2E and 2F).
Menopausal status
Menopause affects the composition of breast tissue even more markedly than age, leading to a
significant replacement of stromal and epithelial tissue by fat. Our results fully agree with these
observations, based on mammography and magnetic resonance imaging (MRI) [31],[34]. As
shown in Table 4, on average the breast has higher water and collagen content, and lower lipid
content before menopause than after it. Correspondingly, in premenopausal women breast tis-
sue scattering is more marked (higher a, suggesting higher density of scattering centers) and
the scattering spectra are steeper (higher b, indicating smaller equivalent size of the scattering
centers), as expected when the ratio of fibrogladular tissue to adipose tissue is higher. The total
hemoglobin content tHb is also markedly higher before menopause than after it.
All these differences between pre- and postmenopausal women closely resemble what is de-
scribed above for the difference between women aged50 y and>50 y. However, interestingly
the menopausal status seems to affect also the blood oxygenation level that is significantly
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higher in premenopausal women than in postmenopausal ones, even though with lower signifi-
cance than all other parameters (p< 0.02 instead of p< 10–4).
The reduced estrogen levels after menopause is expected to lower the metabolic rate. How-
ever, it is not immediately obvious how this could lead to a reduced hemoglobin saturation.
Studies performed on small animals have shown that a marked increase in body fat is not
Fig 2. Dependence of optically derived tissue parameters on age. A) water (blue) and lipid (orange),B) collagen,C) total hemoglobin content tHb, D)
oxygen saturation SO2, E) scattering amplitude a, and F) scattering power b.
doi:10.1371/journal.pone.0128941.g002
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accompanied by a corresponding increase in vascularization, and this leads to hypoxia of the
adipose tissue in obese subjects [35]. Thus, lower levels of hemoglobin oxygenation in post-
menopause women might be related to the significant increase in the adipose fraction of breast
tissue that occurs with menopause. We detect negative correlation between tHb and lipid con-
tent for both pre-menopausal women (Pearson correlation coefficient r = -0.402, p< 0.001)
and post-menopausal women (r = -0.503, p< 0.001), while no significant correlation is ob-
served between SO2 and lipid content. However, this does not rule out the existence of a non-
linear relationship.
It is important to observe that the menopausal status has stronger effect on breast tissue
than just age [31]. In fact, if age-matched subjects are considered, all optically derived parame-
ters are still significantly different (p< 0.01) before versus after menopause, except for the
blood oxygenation level and the scattering slope.
Body Mass Index (BMI)
As displayed in Fig 3A and 3B, for increasing values of BMI a progressive change in breast tis-
sue composition is observed: the amount of lipids increases, while the amounts of water and
collagen decrease, to imply a higher weight of the adipose tissue fraction in the breast of
women with higher BMI. These observations are in agreement with dependence on BMI of
dense breast volume measured by non-contrast MRI [36].
Even though the correlation is weaker than for BMI, the amount of lipids increases as a
function of weight, while the amounts of water and collagen decrease. The opposite trend is ob-
served versus height. These observations (data not shown) are again in agreement with mea-
surements performed with MRI [36][37].
For both blood parameters, the situation is similar to what observed versus age: slight de-
crease in tHb and no significant change in SO2 (Fig 3C and 3D).
The scattering amplitude also shows significant negative correlation with BMI, while the de-
pendence of the scattering power seems to be much weaker (Fig 3E and 3F). As already
Table 3. Tissue composition and scattering parameters of subjects 50 y and > 50 y.
Age Watera (mg/cm3) Lipida (mg/cm3) Collagena (mg/cm3) tHba (μM) SO2
a (%) aa (cm-1) ba (-)
 50 y (N = 101) 261.08 (148.48) 595.45 (129.29) 95.76 (42.32) 13.16 (4.04) 85.48 (10.02) 14.76 (2.74) 0.73 (0.29)
[<10–4]b [<10–4]b [<10–4]b [<10–4]b - [<10–4]b [<10–4]b
> 50 y (N = 99) 119.62 (72.25) 743.08 (102.24) 64.53 (35.37) 10.60 (3.39) 86.07 (8.54) 12.37 (2.36) 0.49 (0.16)
aAverage values and standard deviation (in round brackets).
bIn square brackets, p-value (Mann-Whitney test) for the difference between the mean values reported in the above and below cells. Reported only when
signiﬁcant (p < 0.05).
doi:10.1371/journal.pone.0128941.t003
Table 4. Tissue composition and scattering parameters of pre- and postmenopausal subjects.
Watera (mg/cm3) Lipida (mg/cm3) Collagena (mg/cm3) tHba (μM) SO2
a (%) aa (cm-1) ba (-)
Pre-menopausal (N = 93) 263.05 (148.36) 598.29 (133.48) 98.73 (42.97) 13.64 (4.06) 86.82 (9.64) 14.85 (2.60) 0.70 (0.27)
[<10–4]b [<10–4]b [<10–4]b [<10–4]b [0.02]b [<10–4]b [<10–4]b
Post-menopausal (N = 102) 127.92 (86.30) 729.998 (111.17) 64.25 (34.11) 10.39 (3.21) 84.87 (9.10) 12.44 (2.52) 0.53 (0.24)
aAverage values and standard deviation (in round brackets).
bIn square brackets, p-value (Mann-Whitney test) for the difference between the mean values reported in the above and below cells.
doi:10.1371/journal.pone.0128941.t004
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observed for the dependence on age, a decrease in scattering amplitude and power agrees with
the observed changes in tissue composition that indicate an increase of the adipose component
upon increasing BMI.
Fig 3. Dependence of optically derived tissue parameters on BMI. A) water (blue) and lipid (orange), B) collagen,C) total hemoglobin content tHb, D)
oxygen saturation SO2, E) scattering amplitude a, and F) scattering power b.
doi:10.1371/journal.pone.0128941.g003
Optical Assessment of Breast Tissue Composition
PLOS ONE | DOI:10.1371/journal.pone.0128941 June 1, 2015 10 / 16
Use of Oral Contraceptives (OCs)
For all subjects but two, it was known if they had ever made use of OCs, while for most of them
complete information on the use of OCs (present or past use, duration of use, etc.) was not
available. So, only two groups were considered: women who had never used OCs and women
who had used OCs in the past or were still using them at the time of the optical measurements.
Table 5 compares optically derived parameters obtained on women who used OCs and who
did not use them. Tissue composition (water, lipid and collagen content) and blood parameters
(tHb and SO2) are all significantly different between the two groups, indicating higher water
and collagen content, blood volume and oxygenation level, and lower lipid content in women
who used OCs.
However, it has to be taken into account that women who used OCs were significantly
younger (47.7 ± 8.9 y vs. 55.5 ± 12.3 y) than other women. Based on what described above for
the dependence of optically derived parameters on age, this could at least in part explain the
observed differences between the two groups. Moreover, the group of “OC users” include both
present and past users. So an attempt was made to identify and compare more homogeneous
groups.
For this purpose, we considered subjects in the age range 31–75 y (N = 88 for OC users and
N = 101 for non-users). We further divided the age range in 5-y wide sub-ranges (31–35 y, 36–
40 y, etc.). We estimated the average values of all optically derived parameters within each sub-
range. If the resulting distributions are compared using the paired Student’s t-test, none of the
parameters is significantly different between OC users and non-users. However, the difference
is close to statistical significance for SO2 (p = 0.0594) and collagen content (p = 0.0761).
As mentioned above, the group of OC users include both past users and current users at the
time of the optical measurements. Unfortunately, only a small group of subjects (N = 12) are
known to have been current OC users when the study was performed. Their age ranges be-
tween 30 and 54 y (average age 41.9 ± 7.4 y). In order to observe the effects of OC use indepen-
dent of age, we compared the group of current OC users with subjects who had never used
OCs and belong to the same age range (i.e., 30–54 y). The latter group include N = 54 subjects
with average age 45.2 ± 5.7 y. The age distributions of the two groups are not significantly dif-
ferent (p = 0.106).
When the two groups are compared, on average the trend for tissue composition and blood
parameters is the same as already observed on the full dataset (Table 5), with OC users charac-
terized by higher water, collagen, tHb and SO2, and by lower lipid content. However, the differ-
ences are significant only for tHb (p = 0.0192).
Positive correlation was reported between OC use and breast epithelial proliferation in nor-
mal breast tissue [38]. Increased proliferation may increase the risk of neoplastic transforma-
tion, leading to the well-known increased breast cancer risk observed in OC users [39]. Optical
Table 5. Tissue composition and scattering parameters of subjects who used and who did not use OCs.
Watera (mg/cm3) Lipida (mg/cm3) Collagena (mg/cm3) tHba (μM) SO2
a (%) aa (cm-1) ba (-)
Use of OCs (N = 88) 166.58 (143.51) 664.99 (134.80) 86.67 (44.30) 12.14 (4.16) 89.77 (8.37) 13.49 (2.92) 0.53 (0.27)
[0.0217]b [0.0043]b [0.0004]b [0.0139]b [0.0099]b - -
No use of OCs (N = 110) 120.45 (129.81) 725.30 (137.61) 60.28 (38.17) 10.71 (3.71) 85.71 (9.88) 12.68 (2.71) 0.51 (0.26)
aAverage values and standard deviation (in round brackets).
bIn square brackets, p-value (Mann-Whitney test) for the difference between the mean values reported in the above and below cells. Reported only when
signiﬁcant (p < 0.05).
doi:10.1371/journal.pone.0128941.t005
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measurements have recently allowed to detect a positive correlation between hemoglobin con-
tent in breast cancer tissue and mitotic count score, considered as a proliferative marker [40].
The higher tHb content we observe in OC users might thus be related to OC-induced prolifera-
tion of breast tissue.
Women often report breast tenderness as a side effect of OC use, suggesting that OC use
might lead to an increase in breast water content. However, in univariate analysis per cent
water and total breast water resulted not to be associated with current OC use [37]. As men-
tioned above, the information on OC use at the time of our optical measurements is available
only for N = 12 subjects. This small group of current OC users on average is characterized by
somehow higher water content than N = 54 subjects who are in the same age range and have
never used OCs, but the difference is clearly not significant (224.72 ± 150.67 mg/cm3 vs.
197.03 ± 150.39 mg/cm3, p = 0.3729).
It is interesting to note that the mammographic density as assessed by BI-RADS categories
was not significantly different for OC users vs. non-users. Moreover, the higher collagen con-
tent we observe in breast tissue of OC users (even though the difference is only close to statisti-
cal significance) seems not to agree with the negative correlation between absolute area of
dense breast tissue and years of OC use that has been reported in the literature [2]. However,
the same study did not detect any correlation of the non-dense area with years of OC use. Fur-
thermore, we estimate the amount of collagen per unit volume of breast tissue (mg/cm3). So,
correlation should be more likely occur between collagen content and percentage dense area
than between collagen content and absolute dense area, and the two values (percentage area
and absolute area) not necessarily show strong positive association. Thus, the comparison be-
tween our results and literature data is not straightforward.
Conclusions
We have investigated by non-invasive optical means the dependence of breast tissue composi-
tion (water, lipid and collagen content), blood parameters (total blood volume and oxygen sat-
uration level), and tissue structure (derived from scattering parameters) on breast density, age,
menopausal status, BMI and use of OCs in a group of 200 subjects.
It is important to remind that the optical technique proposed here is safe (no ionizing radia-
tion), practical, repeatable, relatively inexpensive, with good patient acceptance.
As observed by studying OCs users vs non-users, time domain optical measurements can
provide insight into tissue conditions and changes that goes beyond what typically obtained
from x-ray imaging. Optical means yield separate quantitative information on distinct tissue
constituents (and structural parameters). On the contrary, in the case of mammography all
these quantities contribute to determine a single variable, the x-ray attenuation, where
differences in individual parameters may average out with consequent loss of detectable
information.
Breast density depends strongly on tissue composition, which in turn is affected by several
parameters, including age, menopausal status, BMI and use of OCs. Optical probing can be
used to investigate these relationships in vivo to better understand them and to gain insight
into the related breast cancer risk.
In particular, the estimate of collagen content in vivo in breast tissue might also prove useful
for a more direct estimate of cancer risk than provided by the mammographic assessment of
breast density. In fact, collagen is directly involved in cancer development and progression,
and collagen in breast tumor tissue showed to differ from collagen in healthy tissue, both quali-
tatively and quantitatively [41,42,43]. Moreover, collagen is key to determine tissue stiffness
that has recently proved to be significantly associated with breast cancer risk [44].
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Due to the absolute non-invasiveness of the optical technique, young women could also be
monitored gaining useful information on risk prediction and potentially designing dedicated
preventive interventions for subjects that are at high risk.
It has also been suggested that changes in breast density (and consequently in tissue compo-
sition) may be useful in predicting response to chemopreventive treatments aimed at blocking
breast cell proliferation [45].
Moreover, several studies have been published in the last years showing promises of optical
techniques for effective monitoring and even prediction of the response to neoadjuvant chemo-
therapy, and systematic work is now on-going [46][47]. Changes associated with response have
been reported in hemoglobin content and oxygenation level, as most of the optical instruments
available for clinical use focus of the assessment of blood parameters. However, in some cases,
also water or lipid content and scattering power were estimated and proved to correlate with
therapeutic response. On the other side, breast stromal enhancement on MRI was shown to be
associated with response to therapy [48], tissue stiffness estimated by shear-wave elastography
showed promise for response prediction [49], and changes in mammographic breast density
seem predictive of response to adjuvant endocrine therapy [50]. All these results suggest that
monitoring and predicting the response to neoadjuvant chemotherapy may take advantage of a
more thorough estimate of tissue composition and structure, including in particular collagen
that plays major role in determining breast stromal enhancement on MRI, tissue stiffness, and
mammographic density.
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